Literature DB >> 8470761

Complete histologic serial sectioning of a prostate gland with adenocarcinoma.

P A Humphrey1.   

Abstract

Variations in the proportion of surface occupied by tumor (percentage carcinoma), carcinoma volume, histologic grade, capsular penetration, and margin positivity were assessed in a completely sampled cancerous prostate gland. All prostatic tissue was embedded and each block serially sectioned, for a total of 2,678 histologic sections examined. Although variations in percentage carcinoma and carcinoma volume were noted in some blocks, the differences were small when compared with the initial set of 19 slides. Histologic Gleason's grade also showed little variation in the serial sections. Focal capsular penetration in one block and an increase in the number of blocks with a positive anterior margin from two to four were identified in serial sections, but this did not alter the pathologic stage because of seminal vesicle involvement by tumor. In this example, the morphologic prognosticators of tumor volume, histologic grade, margin positivity, and pathologic stage were not altered by complete serial sectioning.

Entities:  

Mesh:

Year:  1993        PMID: 8470761     DOI: 10.1097/00000478-199305000-00005

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  16 in total

1.  Prevalence and risk factors of contralateral extraprostatic extension in men undergoing radical prostatectomy for unilateral disease at biopsy: A global multi-institutional experience.

Authors:  Marc Bienz; Pierre-Alain Hueber; Vincent Trudeau; Abdullah M Alenizi; Roger Valdivieso; Modar Alom; Mevlana Derya Balbay; Abdullah Erdem Canda; Vladimir Mouraviev; David M Albala; Assaad El-Hakim; Quoc-Dien Trinh; Mathieu Latour; Fred Saad; Kevin C Zorn
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

2.  Tissue shrinkage after fixation with formalin injection of prostatectomy specimens.

Authors:  Sara Jonmarker; Alexander Valdman; Anna Lindberg; Magnus Hellström; Lars Egevad
Journal:  Virchows Arch       Date:  2006-08-15       Impact factor: 4.064

Review 3.  Evaluating radical prostatectomy specimens: therapeutic and prognostic importance.

Authors:  D G Bostwick; R Montironi
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

Review 4.  Genomic and phenotypic heterogeneity in prostate cancer.

Authors:  Michael C Haffner; Wilbert Zwart; Martine P Roudier; Lawrence D True; William G Nelson; Jonathan I Epstein; Angelo M De Marzo; Peter S Nelson; Srinivasan Yegnasubramanian
Journal:  Nat Rev Urol       Date:  2020-12-16       Impact factor: 14.432

Review 5.  DNA comparison between operative and biopsy specimens to investigate stage pT0 after radical prostatectomy.

Authors:  Thomas Bessede; Emmanuelle Girodon; Yves Allory; Annick Le Floch; Karen Leroy; Laurent Salomon
Journal:  World J Urol       Date:  2014-03-27       Impact factor: 4.226

6.  Prostate cancer that is within 0.1 mm of the surgical margin of a radical prostatectomy predicts greater likelihood of recurrence.

Authors:  Jason P Izard; Lawrence D True; Philip May; William J Ellis; Paul H Lange; Bruce Dalkin; Daniel W Lin; Rodney A Schmidt; Jonathan L Wright
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

7.  pT0 Prostate Cancer: Predictive Clinicopathologic Features in an American Population.

Authors:  Matthew J Bream; Laila Dahmoush; James A Brown
Journal:  Curr Urol       Date:  2013-07-28

Review 8.  Current status and future prospective of focal therapy for localized prostate cancer: development of multiparametric MRI, MRI-TRUS fusion image-guided biopsy, and treatment modalities.

Authors:  Sunao Shoji; Shinichiro Hiraiwa; Izumi Hanada; Hakushi Kim; Masahiro Nitta; Masanori Hasegawa; Yoshiaki Kawamura; Kazunobu Hashida; Takuma Tajiri; Akira Miyajima
Journal:  Int J Clin Oncol       Date:  2020-02-10       Impact factor: 3.402

Review 9.  Tumor focality in prostate cancer: implications for focal therapy.

Authors:  Markos Karavitakis; Hashim U Ahmed; Paul D Abel; Steven Hazell; Mathias H Winkler
Journal:  Nat Rev Clin Oncol       Date:  2010-11-23       Impact factor: 66.675

Review 10.  Harnessing non-destructive 3D pathology.

Authors:  Jonathan T C Liu; Adam K Glaser; Kaustav Bera; Lawrence D True; Nicholas P Reder; Kevin W Eliceiri; Anant Madabhushi
Journal:  Nat Biomed Eng       Date:  2021-02-15       Impact factor: 25.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.